Acquisition History / Zydus Lifesciences Ltd / Sterling Biotech Ltd - fermentation API business and Masa plant

Zydus Lifesciences Ltd Acquires Sterling Biotech Ltd - fermentation API business and Masa plant

Announced September 17, 2024 — $9.5M

Zydus Lifesciences LtdActive pharmaceutical ingredients2024

What happened

Zydus Lifesciences exercised a pre-agreed right to buy the 'Target Business' of Sterling Biotech - its fermentation-based active pharmaceutical ingredients operations and the production facility at Masa, Gujarat - for Rs 84 crore under a business transfer agreement. Zydus had bought a 50% stake in Sterling Biotech a month earlier, negotiating this call option at a pre-defined value.

Acquirer
Zydus Lifesciences Ltd
Target
Sterling Biotech Ltd - fermentation API business and Masa plant
Announced
September 17, 2024
Price
$9.5M
Industry
Active pharmaceutical ingredients
Buyer type
Strategic acquirer
Status
Announced, not yet closed

By the numbers

Zydus Lifesciences Ltd's acquisition history
1st of 3 tracked deals
Disclosed prices
3 of 3 Zydus Lifesciences Ltd deals
Zydus Lifesciences Ltd's average disclosed price
$158.8M
Zydus Lifesciences Ltd's largest disclosed deal
Amplitude Surgical SA (85.6%) ($300.5M)
Tracked acquisitions in 2024
157 across all acquirers
Zydus Lifesciences Ltd in Active pharmaceutical ingredients
1 acquisition

Frequently Asked Questions About This Acquisition

When did Zydus Lifesciences Ltd acquire Sterling Biotech Ltd - fermentation API business and Masa plant?

Zydus Lifesciences Ltd acquired Sterling Biotech Ltd - fermentation API business and Masa plant on September 17, 2024. This was Zydus Lifesciences Ltd's 1st publicly tracked acquisition out of 3 we have on record.

How much did Zydus Lifesciences Ltd pay for Sterling Biotech Ltd - fermentation API business and Masa plant?

Zydus Lifesciences Ltd paid $9.5M for Sterling Biotech Ltd - fermentation API business and Masa plant.

What does Sterling Biotech Ltd - fermentation API business and Masa plant do?

Zydus Lifesciences exercised a pre-agreed right to buy the 'Target Business' of Sterling Biotech - its fermentation-based active pharmaceutical ingredients operations and the production facility at Masa, Gujarat - for Rs 84 crore under a business transfer agreement. Zydus had bought a 50% stake in Sterling Biotech a month earlier, negotiating this call option at a pre-defined value.

What other Active pharmaceutical ingredients companies has Zydus Lifesciences Ltd acquired?

Sterling Biotech Ltd - fermentation API business and Masa plant is Zydus Lifesciences Ltd's only publicly tracked acquisition in Active pharmaceutical ingredients so far.

Read the full article →

More Zydus Lifesciences Ltd acquisitions

See all 3 Zydus Lifesciences Ltd acquisitions →